Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery
NCT ID: NCT06951893
Last Updated: 2025-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
165 participants
INTERVENTIONAL
2025-05-01
2030-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will be conducted during the usual care of patients undergoing the GEROM73 program, lasting a total of 30 months.
The GEROM73 program includes care for the six months preceding bariatric surgery and the 24 months following surgery. This program supports patients throughout their bariatric care..
Throughout the GEROM73 program, patients will complete questionnaires on anxiety, depression, eating disorders, Impact of Weight on Quality Of Life.
Patients' weight, body mass index and body schema will also be measured throughout the GEROM program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Weight Loss and Metabolic Health After Bariatric Surgery
NCT05987631
Prediction of Response to Bariatric Surgery in Patients With Severe Obesity
NCT06426290
Risk Factors of Depression, Anxiety and Eating Disorder After Bariatric Surgery
NCT06491069
Predictors of Anesthesia Complications in Patients Undergoing Bariatric Surgery
NCT06981793
Obesity and Bariatric Surgery According to a Biopsychosocial Perspective.
NCT05950698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
phenotype of patients during the GEROM73 program
Anxiety, Depression, Eating disorders, Impact of Weight on Quality Of Life.Patients' weight, Body Mass index and Body schema
Hospital Anxiety and Depression Scale
It is a self-assessment questionnaire to identify the existence of anxious and depressive symptoms and to assess their severity.
Dutch Eating Behaviour Questionnary
It allows the assessment of 3 distinct factors of eating behavior: cognitive restriction, emotional eating and externality. This tool was developed to better characterize the eating habits of obese subjects.
10min
Impact of Weight on Quality Of Life
The EQVOD is a validated French scale created from the Impact of Weight on Quality of Life (IWQOL) questionnaire. This self-administered questionnaire is specific to the sociocultural factors of obesity and its dietary treatment in France. The questionnaire is composed of five dimensions: physical impact (11 items), psychosocial impact (11 items), impact on sexual life (4 items), dietary well-being (5 items), and experience of diet/dietetics (5 items). The total number of items is 36.
body schema
Tactile assessment of the body schema using a motorized caliper applied to different parts of the individual's body. The caliper is connected to a touch pad on which the person can report the difference felt between the two pressure points on their skin, using their thumb and index finger.
body mass index
patient weighing at each visit
waist size
waist size measure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hospital Anxiety and Depression Scale
It is a self-assessment questionnaire to identify the existence of anxious and depressive symptoms and to assess their severity.
Dutch Eating Behaviour Questionnary
It allows the assessment of 3 distinct factors of eating behavior: cognitive restriction, emotional eating and externality. This tool was developed to better characterize the eating habits of obese subjects.
10min
Impact of Weight on Quality Of Life
The EQVOD is a validated French scale created from the Impact of Weight on Quality of Life (IWQOL) questionnaire. This self-administered questionnaire is specific to the sociocultural factors of obesity and its dietary treatment in France. The questionnaire is composed of five dimensions: physical impact (11 items), psychosocial impact (11 items), impact on sexual life (4 items), dietary well-being (5 items), and experience of diet/dietetics (5 items). The total number of items is 36.
body schema
Tactile assessment of the body schema using a motorized caliper applied to different parts of the individual's body. The caliper is connected to a touch pad on which the person can report the difference felt between the two pressure points on their skin, using their thumb and index finger.
body mass index
patient weighing at each visit
waist size
waist size measure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Integrated into the GEROM73 surgical program and starting the intra-hospital program
Exclusion Criteria
* Patients with cognitive disorders
* Patients with difficulties understanding the French language, spoken or written
* Pregnant, parturient, or breastfeeding women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Metropole Savoie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cécile BOSSU ESTOUR
Role: PRINCIPAL_INVESTIGATOR
CH Metropole Savoie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Métropole Savoie
Chambéry, Savoie, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHMS24006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.